The product has been approved by the US Food and Drug Administration (FDA) as a first-line
therapy indicated to treat patients with advanced renal cell carcinoma (RCC).
M2 PHARMA-June 29, 2017-EC approves first-line
use of Novartis' Zykadia in ALK-positive advanced non-small cell lung cancer
Novartis today announced the US Food and Drug Administration (FDA) approved the expanded use of Zykadia (ceritinib) to include the first-line
treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, as detected by an FDA-approved test.
India has the largest private TB drug market, with rampant proliferation of first-line
TB drugs in a wide variety of dosages and combinations.
BERLIN - People never treated for their chronic migraines and those who failed a previous first-line
medication reported similar reductions in frequency of headache days after treatment with onabotulinumtoxinA in a post hoc comparison study of the two phase III studies that Allergan used to gain approval for the new indication.
Without the activism noted below, the price could have been more than twice as high--preventing the drug from ever being widely used for first-line
treatment, where the need is not immediate and desperate, since other good treatments are available for these patients.
entries are cross-referenced to the song title, which in turn is cross-referenced by number to the bibliography.
The product is also in numerous phase II clinical trials for several other cancer indications, including first-line
Health outcomes associated with calcium antagonists compared with other first-line
antihypertensive therapies: a meta-analysis of randomised controlled trials.
However, in a 3-2 victory over the Edmonton Oilers on Friday night in front of an announced crowd of 13,592 at The Pond, it was the big-name, first-line
players that made the difference.
Standard short-course therapy with first-line
medications does not reduce the prevalence of multidrug-resistant tuberculosis in countries with substantial levels of resistant disease, said Dr.
supervisors, on average, earn 13 percent more than team leaders.